Explorative Study on Isolation and Characterization of a Microviridae G4 Bacteriophage, EMCL318, against Multi-Drug-resistant Escherichia coli 15-318
- PMID: 30373114
- PMCID: PMC6316680
- DOI: 10.3390/antibiotics7040092
Explorative Study on Isolation and Characterization of a Microviridae G4 Bacteriophage, EMCL318, against Multi-Drug-resistant Escherichia coli 15-318
Abstract
Bacteriophages screened and isolated from sewage water samples exhibited antibacterial activities against multi-drug-resistant Escherichia coli strains. Five different water samples from Canadian habitats such as Kamloops Wastewater Treatment Center, Domtar, the Pacific Ocean, Bisaro Anima Cave, and alkali ponds, were used in this study. Four Enterobacteriaceae strains including one non-resistant and three clinical multi-drug Escherichia coli strains (E. coli 15-102, E. coli 15-124, and E. coli 15-318) were selected as target bacteria to screen for the bacteriophages from these collected water samples. Seeded agar assay technique was implemented for the screening. It was found that only sewage water sample exhibited a significant number of plaques count with the E. coli 15-318 (1.82 × 10² plaques/plate) cells in comparison to E. coli non-resistant strain K12 (8 plaques/plate). The phage did not produce plaques in the E. coli 15-124 and E. coli 15-102 strains. The bacteriophage, designated EMCL318, was isolated, purified, characterized, and identified to belong to the G4 species of the Family Microviridae, GenBank accession number MG563770. This is an explorative study conducted in order to reveal the viruses as alternative potentials to fight against emerging and existing multi-drug-resistant infectious diseases.
Keywords: Multi-drug-resistant organisms; alternative therapeutic measures; bacteriophages; phage therapy.
Conflict of interest statement
The authors are not aware of any potential conflict of interest.
Figures




Similar articles
-
Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli.Jundishapur J Microbiol. 2015 Feb 20;8(2):e17744. doi: 10.5812/jjm.17744. eCollection 2015 Feb. Jundishapur J Microbiol. 2015. PMID: 25834712 Free PMC article.
-
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Klebsiella pneumoniae in a burn patient and its effects on bacterial biofilm].Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004. Zhonghua Shao Shang Za Zhi. 2020. PMID: 32023713 Chinese.
-
Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species.Front Microbiol. 2019 Mar 21;10:574. doi: 10.3389/fmicb.2019.00574. eCollection 2019. Front Microbiol. 2019. PMID: 30949158 Free PMC article.
-
Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against Multi-Drug Resistant Escherichia coli 3.Jundishapur J Microbiol. 2015 Nov 21;8(11):e25917. doi: 10.5812/jjm.25917. eCollection 2015 Nov. Jundishapur J Microbiol. 2015. PMID: 26865936 Free PMC article.
-
Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.PLoS One. 2017 Jul 18;12(7):e0179245. doi: 10.1371/journal.pone.0179245. eCollection 2017. PLoS One. 2017. PMID: 28719657 Free PMC article.
Cited by
-
Taxonomic and Metabolite Diversities of Moss-Associated Actinobacteria from Thailand.Metabolites. 2021 Dec 27;12(1):22. doi: 10.3390/metabo12010022. Metabolites. 2021. PMID: 35050144 Free PMC article.
-
Synergistic action of phages and lytic proteins with antibiotics: a combination strategy to target bacteria and biofilms.BMC Microbiol. 2023 May 23;23(1):149. doi: 10.1186/s12866-023-02881-2. BMC Microbiol. 2023. PMID: 37221517 Free PMC article.
References
-
- Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources